{"product_id":"liposomal-vitamin-k2-mk-7-powder-nlt-1500-mcg-g","title":"Vezicle™ Liposomal Vitamin K2 MK-7 Powder, NLT 1,500 µg\/g","description":"\u003cp\u003e\u003cstrong\u003eLiposomal Vitamin K2 MK-7 Powder is a single-active, immediate-release ingredient developed for low-dose uniformity and dispersion in professional supplement formulations.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt provides NLT 1,500 µg\/g vitamin K2 as menaquinone-7 in a characterised phospholipid vesicle powder for premixes, capsules, tablets and powder blends.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLow-dose formulation:\u003c\/strong\u003e designed to support uniform distribution, dispersion and dry-powder handling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCharacterised structure:\u003c\/strong\u003e liposomal terminology is supported by phospholipid vesicle characterisation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEvidence-led supply:\u003c\/strong\u003e manufactured and released against an approved specification, with batch-specific results reported by Certificate of Analysis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eQualified \/ in stock · 50 g evaluation sample at €40 ex VAT · Typical lead time 3–5 business days\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe evaluation-sample fee is credited against the first commercial order placed within 12 months. The TDS, finished-product specification, batch CoA, SDS and liposomal characterisation data are available on request.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eNo absorption or human-bioavailability claim is made.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch2\u003eWhat is the technical summary?\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eProduct code\u003c\/th\u003e\n\u003ctd\u003eNG-LIP-001\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eActive ingredient\u003c\/th\u003e\n\u003ctd\u003eVitamin K2 as menaquinone-7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay\u003c\/th\u003e\n\u003ctd\u003eNLT 1,500 µg\/g vitamin K2 as MK-7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTechnology\u003c\/th\u003e\n\u003ctd\u003eLiposomal delivery\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDelivery system\u003c\/th\u003e\n\u003ctd\u003eCharacterised phospholipid vesicle system\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eProduct format\u003c\/th\u003e\n\u003ctd\u003eSingle-active dry powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRelease behaviour\u003c\/th\u003e\n\u003ctd\u003eImmediate \/ non-modified\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eProduct status\u003c\/th\u003e\n\u003ctd\u003eQualified \/ in stock\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eBest-fit applications\u003c\/th\u003e\n\u003ctd\u003ePremixes, capsules, tablets and powder blends\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eHow can B2B buyers order and request documentation?\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eEvaluation sample\u003c\/th\u003e\n\u003ctd\u003e50 g — €40 ex VAT\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample-fee credit\u003c\/th\u003e\n\u003ctd\u003eCredited against the first commercial order within 12 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStocked MOQ\u003c\/th\u003e\n\u003ctd\u003e1 kg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStandard packs\u003c\/th\u003e\n\u003ctd\u003e1 kg and 5 kg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eBulk pack\u003c\/th\u003e\n\u003ctd\u003e25 kg by quotation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTypical lead time\u003c\/th\u003e\n\u003ctd\u003e3–5 business days when in stock\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDocumentation\u003c\/th\u003e\n\u003ctd\u003eCurrent technical and quality package available on request\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eCustom strength\u003c\/th\u003e\n\u003ctd\u003eSubject to technical and commercial feasibility\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eCustom packaging\u003c\/th\u003e\n\u003ctd\u003eAvailable by quotation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhich formulation problems does this ingredient address?\u003c\/h2\u003e\n\u003ch3\u003eWhy is vitamin K2 MK-7 difficult to formulate at low dose?\u003c\/h3\u003e\n\u003cp\u003eVitamin K2 MK-7 is incorporated at microgram-level doses, making uniform distribution across larger powder blends an important formulation consideration. The ingredient may also be affected by light, oxidation, alkaline conditions and direct interaction with certain minerals or other formulation components.\u003c\/p\u003e\n\u003ch3\u003eHow does the NexaGens format address the formulation challenge?\u003c\/h3\u003e\n\u003cp\u003eThis liposomal Vitamin K2 powder uses a characterised phospholipid vesicle system in a dry, single-active format. It is designed to support low-dose distribution, dispersion and protection from formulation stress while retaining immediate, non-modified release.\u003c\/p\u003e\n\u003cp\u003eThe ingredient can be used as an independent formulation module and assessed alongside other ingredients according to the requirements of the finished product.\u003c\/p\u003e\n\n\u003ch2\u003eWhat is the full technical specification?\u003c\/h2\u003e\n\u003cp\u003eThe key public specification is NLT 1,500 µg\/g vitamin K2 as MK-7 with Immediate \/ non-modified release behaviour; batch acceptance follows the approved product-specific specification and analytical method.\u003c\/p\u003e\n\u003cp\u003eThe product is manufactured and released against an approved finished-product specification. Applicable controls cover:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eIdentity and vitamin K2 MK-7 assay\u003c\/li\u003e\n\u003cli\u003eMK-7 profile\u003c\/li\u003e\n\u003cli\u003ePhospholipid vesicle characterisation\u003c\/li\u003e\n\u003cli\u003eParticle-size characteristics\u003c\/li\u003e\n\u003cli\u003eBulk and tapped density\u003c\/li\u003e\n\u003cli\u003eMoisture or loss on drying\u003c\/li\u003e\n\u003cli\u003eWater activity\u003c\/li\u003e\n\u003cli\u003eDispersibility and powder handling\u003c\/li\u003e\n\u003cli\u003eAppearance, colour and odour\u003c\/li\u003e\n\u003cli\u003eMicrobiological limits\u003c\/li\u003e\n\u003cli\u003eHeavy metals and applicable contaminants\u003c\/li\u003e\n\u003cli\u003eResidual-solvent compliance\u003c\/li\u003e\n\u003cli\u003eStorage conditions and shelf life\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDetailed numerical limits are provided in the current finished-product specification. Batch-specific results are reported in the Certificate of Analysis.\u003c\/p\u003e\n\n\u003ch2\u003eWhat is the public composition?\u003c\/h2\u003e\n\u003cp\u003eThe public composition identifies Vitamin K2 MK-7 with a Food-grade phospholipid delivery system and powder carrier; exact proprietary excipient ratios and supplier details remain controlled.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eComponent\u003c\/th\u003e\n\u003cth\u003eFunction\u003c\/th\u003e\n\u003cth\u003ePublic information\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVitamin K2 MK-7\u003c\/td\u003e\n\u003ctd\u003eActive ingredient\u003c\/td\u003e\n\u003ctd\u003eMenaquinone-7 from a product-specific qualified source; NLT 1,500 µg\/g\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFood-grade phospholipid system\u003c\/td\u003e\n\u003ctd\u003eVesicle-forming delivery system\u003c\/td\u003e\n\u003ctd\u003eControlled product-specific phospholipid composition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFood-grade carrier and protective matrix\u003c\/td\u003e\n\u003ctd\u003ePowder formation and physical stability\u003c\/td\u003e\n\u003ctd\u003eProduct-specific carrier system, q.s. to 100%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eExact proprietary quantities are maintained in the controlled product dossier. Country of origin is stated in the current Country of Origin Statement.\u003c\/p\u003e\n\n\u003ch2\u003eHow is performance verified?\u003c\/h2\u003e\n\u003cp\u003ePerformance is verified using approved product-specific methods and the controlled evidence listed below.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eVerification area\u003c\/th\u003e\n\u003cth\u003eEvidence\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIdentity and assay\u003c\/td\u003e\n\u003ctd\u003eApproved finished-product specification and batch Certificate of Analysis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiposomal structure\u003c\/td\u003e\n\u003ctd\u003eCharacterisation of the phospholipid vesicle system\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStability and shelf life\u003c\/td\u003e\n\u003ctd\u003eCurrent product-specific stability documentation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMicrobiological quality\u003c\/td\u003e\n\u003ctd\u003eFinished-product microbiological specification\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHeavy metals and contaminants\u003c\/td\u003e\n\u003ctd\u003eApproved finished-product specification\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe liposomal terminology applies to the characterised supplied ingredient. Performance in a finished product must be confirmed in the customer’s formulation and manufacturing process.\u003c\/p\u003e\n\n\u003ch2\u003eHow should formulators process and evaluate it?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePre-disperse the ingredient where required by the dosage form or manufacturing process.\u003c\/li\u003e\n\u003cli\u003eMinimise prolonged exposure to heat, moisture and direct light.\u003c\/li\u003e\n\u003cli\u003eAvoid strong oxidants and extreme-pH processing conditions.\u003c\/li\u003e\n\u003cli\u003eAssess compatibility with minerals, surfactants and other formulation components.\u003c\/li\u003e\n\u003cli\u003eVerify low-dose uniformity across the final blend.\u003c\/li\u003e\n\u003cli\u003eConfirm stability and performance in the finished product.\u003c\/li\u003e\n\u003cli\u003eFollow the product-specific reconstitution and dispersion protocol.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhich technical and quality documents are available?\u003c\/h2\u003e\n\u003ch3\u003eCore technical documents\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eTechnical Data Sheet\u003c\/li\u003e\n\u003cli\u003eFinished Product Specification\u003c\/li\u003e\n\u003cli\u003eBatch Certificate of Analysis\u003c\/li\u003e\n\u003cli\u003eSafety Data Sheet\u003c\/li\u003e\n\u003cli\u003eLiposomal Characterisation Data\u003c\/li\u003e\n\u003cli\u003eStability Documentation\u003c\/li\u003e\n\u003cli\u003eComposition and Ingredient Information\u003c\/li\u003e\n\u003cli\u003eStorage and Handling Information\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eQuality and compliance documents\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAllergen Statement\u003c\/li\u003e\n\u003cli\u003eGMO Statement\u003c\/li\u003e\n\u003cli\u003eIrradiation Statement\u003c\/li\u003e\n\u003cli\u003eBSE\/TSE Statement\u003c\/li\u003e\n\u003cli\u003eMicrobiological Specification\u003c\/li\u003e\n\u003cli\u003eHeavy Metals Specification\u003c\/li\u003e\n\u003cli\u003eCountry of Origin Statement\u003c\/li\u003e\n\u003cli\u003eManufacturing or Quality Certificate\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFull controlled composition or characterisation details may require an NDA. Tell NexaGens which documents you require and whether they are needed for evaluation, formulation, supplier qualification or regulatory review.\u003c\/p\u003e\n\n\u003ch2\u003eWhat must buyers confirm for regulatory and intended use?\u003c\/h2\u003e\n\u003cp\u003eRegulatory suitability depends on the intended use, dose and target market; the customer must confirm finished-product compliance.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eTarget market\u003c\/th\u003e\n\u003ctd\u003eEuropean Union \/ EEA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eIntended use\u003c\/th\u003e\n\u003ctd\u003eFood supplements and professional formulation use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLabel declaration\u003c\/th\u003e\n\u003ctd\u003eVitamin K2 MK-7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eIngredient legal status\u003c\/th\u003e\n\u003ctd\u003eProduct-specific assessment available; intended use and national requirements must be confirmed by the customer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eNovel-food review\u003c\/th\u003e\n\u003ctd\u003eProduct-specific assessment available\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eCarrier compliance\u003c\/th\u003e\n\u003ctd\u003eReviewed for the intended product scope\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAllergen and GMO status\u003c\/th\u003e\n\u003ctd\u003eConfirm against the current product-specific declarations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eVegan, vegetarian, halal and kosher status\u003c\/th\u003e\n\u003ctd\u003eConfirm against the applicable current statement or certificate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eUse level\u003c\/th\u003e\n\u003ctd\u003eDetermined by the customer’s formulation, applicable legislation and technical assessment\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eHow should it be stored and handled?\u003c\/h2\u003e\n\u003cp\u003eStore tightly closed in original packaging in a cool, dry place, protected from heat, moisture and direct light. Free-flowing powder with product-specific colour and odour; see TDS and batch CoA.\u003c\/p\u003e\n\u003cp\u003eReseal promptly after opening and follow the storage conditions stated in the current Technical Data Sheet and stability documentation.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003ch3\u003eIs this a characterised liposomal ingredient?\u003c\/h3\u003e\n\u003cp\u003eYes. NexaGens uses liposomal terminology because phospholipid vesicle structure has been characterised for the supplied ingredient. Supporting characterisation data are available on request.\u003c\/p\u003e\n\u003ch3\u003eIs it immediate or modified release?\u003c\/h3\u003e\n\u003cp\u003eIt is an immediate, non-modified-release powder. No sustained-release or enteric-release claim is made.\u003c\/p\u003e\n\u003ch3\u003eWhich applications are suitable?\u003c\/h3\u003e\n\u003cp\u003ePotential applications include premixes, capsules, tablets and powder blends. Final suitability depends on the complete formulation and manufacturing process.\u003c\/p\u003e\n\u003ch3\u003eCan it be combined with other ingredients?\u003c\/h3\u003e\n\u003cp\u003eIt may be combined with other formulation components or independent NexaGens modules. Compatibility, low-dose uniformity and stability must be confirmed in the finished product.\u003c\/p\u003e\n\u003ch3\u003eWhat documentation is available?\u003c\/h3\u003e\n\u003cp\u003eThe available package includes the TDS, finished-product specification, batch CoA, SDS, liposomal characterisation data and applicable quality, regulatory and stability documents.\u003c\/p\u003e\n\u003ch3\u003eCan I order an evaluation sample?\u003c\/h3\u003e\n\u003cp\u003eYes. A 50 g evaluation sample is available for €40 ex VAT. The fee is credited against the first commercial order placed within 12 months.\u003c\/p\u003e\n\u003ch3\u003eWhat is the commercial MOQ?\u003c\/h3\u003e\n\u003cp\u003eThe stocked commercial MOQ is 1 kg. Standard packs are 1 kg and 5 kg, while 25 kg quantities are supplied by quotation.\u003c\/p\u003e\n\n\u003ch2\u003eWhat does NexaGens not claim?\u003c\/h2\u003e\n\u003cp\u003eFor professional B2B food, food-supplement and formulation use only. Not intended for direct consumer use.\u003c\/p\u003e\n\u003cp\u003eNo medicinal, disease-treatment, absorption or human-bioavailability claim is made. Performance depends on the complete formulation and processing conditions. The customer remains responsible for confirming dosage, permitted use, product classification, label declarations, claims and market compliance.\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"50 g","offer_id":58642184405340,"sku":"NG-LIP-001-50g","price":40.0,"currency_code":"EUR","in_stock":true},{"title":"1 kg","offer_id":58828844368220,"sku":"NG-LIP-001-1kg","price":130.0,"currency_code":"EUR","in_stock":true},{"title":"5 kg","offer_id":58828844400988,"sku":"NG-LIP-001-5kg","price":525.0,"currency_code":"EUR","in_stock":true}],"url":"https:\/\/nexagens.com\/products\/liposomal-vitamin-k2-mk-7-powder-nlt-1500-mcg-g","provider":"NexaGens","version":"1.0","type":"link"}